PCDHB5: A Potential Drug Target for Cardiovascular Disease (G26167)

Target Name: PCDHB5

NCBI ID: G26167

PCDHB5

PCDHB5: A Potential Drug Target for Cardiovascular Disease

PCDHB5 (polycystic density-sensitive heart ion channel subfamily B member 5) is a protein that is expressed in many different tissues throughout the body, including the heart, kidneys, and pancreas. It is a member of the PCDHB5 gene family, which encodes a family of transmembrane proteins that are known as ion channels. These proteins play a crucial role in the regulation of ion traffic and are involved in a wide range of physiological processes, including heart rhythm and blood pressure.

One of the unique features of PCDHB5 is its ability to sense changes in the electrical activity of the heart. This property makes it an attractive drug target, as drugs that can modulate PCDHB5 function have the potential to treat a variety of cardiovascular and other conditions.

PCDHB5 is expressed in the heart and is involved in the regulation of the heart's electrical activity. It is thought to play a role in the mechanism of action of many different drugs that are used to treat cardiovascular disease, including beta-blockers, calcium channel blockers, and ACE inhibitors.

In addition to its role in heart function, PCDHB5 is also involved in the regulation of blood pressure and the maintenance of blood volume. It is thought to be involved in the regulation of sodium and potassium channels, which are involved in the flow of electrical current through the heart and blood vessels.

PCDHB5 is also involved in the regulation of stem cell proliferation and the maintenance of tissue homeostasis. It is thought to play a role in the development and maintenance of the myocardium, which is the heart muscle, as well as the regulation of immune cell function.

Despite its involvement in a wide range of physiological processes, PCDHB5 is relatively well-studied, and there is currently a lack of specific drugs that can modulate its function. This is likely to change in the future, as researchers continue to study PCDHB5 and its role in the regulation of ion traffic and other physiological processes.

In conclusion, PCDHB5 is a protein that is involved in a wide range of physiological processes in the body, including heart function, blood pressure, and tissue homeostasis. Its unique ability to sense changes in electrical activity of the heart makes it an attractive drug target, and there is currently a lack of specific drugs that can modulate its function. Further research is needed to understand fully the role of PCDHB5 in the regulation of ion traffic and other physiological processes, and to develop drugs that can modulate its function for the treatment of cardiovascular and other conditions.

Protein Name: Protocadherin Beta 5

Functions: Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain

The "PCDHB5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PCDHB5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets